Similar articles

• The design of prophylactic trials for HIV: the case of microbicides.

  Stein ZA, Myer L, Susser M. Stein ZA, et al. Epidemiology. 2003 Jan;14(1):80-3; discussion 83-4. doi: 10.1097/00001648-200301000-00018. Epidemiology. 2003. PMID: 12500050 No abstract available.
• The slow evolution of microbicides for STD/HIV prevention.

  Howes J, Bass M. Howes J, et al. J Gend Specif Med. 1999 May-Jun;2(3):22-3. J Gend Specif Med. 1999. PMID: 11252848 No abstract available.
• AIDS research. Microbicide fails to protect against HIV.

  Cohen J. Cohen J. Science. 2008 Feb 22;319(5866):1026-7. doi: 10.1126/science.319.5866.1026b. Science. 2008. PMID: 18292313 No abstract available.
• Vaginal microbicides.

  O'Brien RF. O'Brien RF. Adolesc Med Clin. 2006 Oct;17(3):673-85; abstract xi. doi: 10.1016/j.admecli.2006.06.004. Adolesc Med Clin. 2006. PMID: 17030285 Review.
• Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going?

  Elias C, Coggins C. Elias C, et al. J Womens Health Gend Based Med. 2001 Mar;10(2):163-73. doi: 10.1089/152460901300039502. J Womens Health Gend Based Med. 2001. PMID: 11268299 Review.